BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 9562450)

  • 1. A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors.
    Voss MH; Feldman DR; Bosl GJ; Motzer RJ
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):557-76, viii -ix. PubMed ID: 21570609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canadian consensus guidelines for the management of testicular germ cell cancer.
    Wood L; Kollmannsberger C; Jewett M; Chung P; Hotte S; O'Malley M; Sweet J; Anson-Cartwright L; Winquist E; North S; Tyldesley S; Sturgeon J; Gospodarowicz M; Segal R; Cheng T; Venner P; Moore M; Albers P; Huddart R; Nichols C; Warde P
    Can Urol Assoc J; 2010 Apr; 4(2):e19-38. PubMed ID: 20368885
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inductive systemic therapy of urological tumors with curative intent].
    vom Dorp F; Krege S; Rübben H
    Urologe A; 2007 Oct; 46(10):1400-3. PubMed ID: 17874061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy for recurrent testicular cancer].
    Kuczyk M; Horstmann M; Merseburger A; Beyer J
    Urologe A; 2005 Apr; 44(4):352-7. PubMed ID: 15756533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differentiation status of primary gonadal germ cell tumors correlates inversely with telomerase activity and the expression level of the gene encoding the catalytic subunit of telomerase.
    Schrader M; Burger AM; Müller M; Krause H; Straub B; Schostak M; Schulze W; Lauke H; Miller K
    BMC Cancer; 2002 Nov; 2():32. PubMed ID: 12459049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of germ cell tumors at the threshold of the third millennium].
    Géczi L; Biron P; Droz JP
    Orv Hetil; 2001 Aug; 142(31):1673-9. PubMed ID: 11556261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours.
    Fosså SD; Stenning SP; Gerl A; Horwich A; Clark PI; Wilkinson PM; Jones WG; Williams MV; Oliver RT; Newlands ES; Mead GM; Cullen MH; Kaye SB; Rustin GJ; Cook PA
    Br J Cancer; 1999 Jul; 80(9):1392-9. PubMed ID: 10424741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era.
    Sonneveld DJ; Hoekstra HJ; van der Graaf WT; Sluiter WJ; Mulder NH; Willemse PH; Koops HS; Sleijfer DT
    Cancer; 2001 Apr; 91(7):1304-15. PubMed ID: 11283931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by Cox regression and recursive partitioning.
    van Dijk MR; Steyerberg EW; Stenning SP; Dusseldorp E; Habbema JD
    Br J Cancer; 2004 Mar; 90(6):1176-83. PubMed ID: 15026798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germ cell tumours of the testis: clinical features, treatment outcome and prognostic factors.
    Bhutani M; Kumar L; Seth A; Thulkar S; Vijayaraghavan M; Kochupillai V
    Natl Med J India; 2002; 15(1):18-21. PubMed ID: 11855586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in metastatic germ cell tumors.
    Schmoll HJ; Beyer J
    Semin Oncol; 1998 Apr; 25(2):174-85. PubMed ID: 9562450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.